CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-11 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2025-03-13 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2024-03-06 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +15,700 | 15,700 | ||
| 2023-12-13 | Vance Terry Director | Sale | −15,295 | $9.12 | $139K | 5,800 |
| 2023-03-16 | Vance Terry Director | Option exercise | +5,800 | $14.00 | $81K | 21,095 |
| 2023-03-16 | Vance Terry Director | Option exercise · Stock Option (right to buy) | −5,800 | 0 | ||
| 2023-03-02 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +10,800 | 10,800 | ||
| 2022-03-03 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2021-03-02 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 |
Page 1 of 1 · 9 trades